Current Pharmaceutical Biotechnology,volume 14,issue 12  (01-2013)

Period of time： 2013年12期

Publisher： Bentham Science Publishers

Founded in： 2000

Total resources： 157

E-ISSN： 1873-4316|14|12

ISSN： 1389-2010

Subject： R9 Pharmacy

Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Current Pharmaceutical Biotechnology,volume 14,issue 12

Menu

Luteolin Inhibits Smooth Muscle Cell Migration and Proliferation by Attenuating the Production of Nox4, P-Akt and VEGF in Endothelial Cells

Current Pharmaceutical Biotechnology,volume 14,issue 12 , Vol. 14, Iss. 12, 2013-11 , pp. 1009-1015

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Pharmaceutical Applications of Graphene-based Nanosheets

Current Pharmaceutical Biotechnology,volume 14,issue 12 , Vol. 14, Iss. 12, 2013-11 , pp. 1016-1026

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Pterostilbene as a Potential Novel Telomerase Inhibitor: Molecular Docking Studies and Its in vitro Evaluation

Current Pharmaceutical Biotechnology,volume 14,issue 12 , Vol. 14, Iss. 12, 2013-11 , pp. 1027-1035

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Development and Characterization of a Gel Formulation Integrating Microencapsulated Nitrofurazone

Current Pharmaceutical Biotechnology,volume 14,issue 12 , Vol. 14, Iss. 12, 2013-11 , pp. 1036-1047

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Construction of an Anti-IL-1&bgr; scfv and TNFRI Fusion Protein and Its Therapeutic Effect on RA Mice Model

Current Pharmaceutical Biotechnology,volume 14,issue 12 , Vol. 14, Iss. 12, 2013-11 , pp. 1048-1061

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

In vivo behavior and Safety of Lapatinib-Incorporated Lipid Nanoparticles

Current Pharmaceutical Biotechnology,volume 14,issue 12 , Vol. 14, Iss. 12, 2013-11 , pp. 1062-1071

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Developing Immunologically Inert Adeno-Associated Virus (AAV) Vectors for Gene Therapy: Possibilities and Limitations

Current Pharmaceutical Biotechnology,volume 14,issue 12 , Vol. 14, Iss. 12, 2013-01 , pp. 1072-1082

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Total 7 item(s)